|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61P 7/06 | |||
| A61K 38/45 | |||
| A61K 45/06 | |||
| A61K 38/00 | |||
| C12N 9/12 |
| (11) | Number of the document | 3520805 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19161424.7 |
| Date of filing the European patent application | 2012-10-17 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161547932 P | 2011-10-17 | US |
| (72) |
SEEHRA, Jasbir, US
PEARSALL, Robert, Scott, US
KUMAR, Ravindra, US
SURAGANI, Naga, Venkata Sai Rajasekhar, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS FOR TREATING MYELOFIBROSIS |
| COMPOSITIONS FOR TREATING MYELOFIBROSIS |